Holen Sie sich die Stockscreener-App
0.4959
10.66%
-0.0592
Vorhandelsmarkt:
.51
0.0141
+2.84%
Schlusskurs vom Vortag:
$0.5551
Offen:
$0.5231
24-Stunden-Volumen:
664.09K
Relative Volume:
0.98
Marktkapitalisierung:
$2.81M
Einnahmen:
$2.05M
Nettoeinkommen (Verlust:
$-30.96M
KGV:
-0.00908
EPS:
-54.6022
Netto-Cashflow:
$-17.93M
1W Leistung:
-13.86%
1M Leistung:
-38.86%
6M Leistung:
-85.50%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.4853
$0.55
1-Wochen-Bereich:
$0.4795
$0.77
52-Wochen-Spanne:
$0.4795
$6.17
Bnb Plus Corp Stock (BNBX) Company Profile
Firmenname
Bnb Plus Corp
Sektor
Branche
Telefon
631-240-8800
Adresse
50 HEALTH SCIENCES DRIVE, STONY BROOK
Compare BNBX vs BLK, BN, BX, KKR, BAM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BNBX
Bnb Plus Corp
|
0.4959 | 2.81M | 2.05M | -30.96M | -17.93M | -54.60 |
BLK
Blackrock Inc
|
1,042.85 | 162.02B | 26.31B | 6.75B | 3.75B | 39.42 |
BN
Brookfield Corp
|
46.44 | 103.89B | 77.49B | 3.24B | -3.80B | 0.4932 |
BX
Blackstone Inc
|
128.50 | 99.80B | 14.02B | 6.05B | 1.74B | 3.8674 |
KKR
Kkr Co Inc
|
104.45 | 93.12B | 20.26B | 6.15B | 9.52B | 2.3271 |
BAM
Brookfield Asset Management Ltd
|
48.22 | 78.99B | 4.82B | 2.40B | 2.28B | 1.5287 |
Bnb Plus Corp Stock (BNBX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-02-12 | Eingeleitet | ROTH Capital | Buy |
| 2021-01-14 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-18 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-20 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-11-14 | Bestätigt | Maxim Group | Buy |
| 2016-05-13 | Bestätigt | Maxim Group | Buy |
| 2015-10-08 | Bestätigt | Maxim Group | Buy |
| 2015-05-26 | Eingeleitet | The Benchmark Company | Speculative Buy |
| 2015-02-10 | Bestätigt | Maxim Group | Buy |
| 2015-01-13 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Bnb Plus Corp Aktie (BNBX) Neueste Nachrichten
BNB Plus Corp. Announces Review of Strategic Alternatives to Maximize Shareholder Value - Binance
BNB Plus faces the risk of delisting from Nasdaq and has initiated an evaluation of the shareholder value maximization strategy - WEEX
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
BNB Plus (BNBX) Stock Rises 9.4% Amid Strategic Review Announcem - GuruFocus
BNB Plus reviews strategic alternatives, treasury at $12.2M By Investing.com - Investing.com South Africa
Unusual volume stocks are being observed in Monday's session. - ChartMill
BNBX Pursues Strategic Alternatives to Enhance Shareholder Value - GuruFocus
BC-Most Active Stocks - WFMZ.com
BNB Plus Corp. receives non-compliance notice from Nasdaq - TipRanks
BNB Plus stock jumps after starting strategic review (BNBX:NASDAQ) - Seeking Alpha
BNB Plus Corp. announces review of strategic alternatives - TipRanks
BNB Plus reviews strategic alternatives, treasury at $12.2M - Investing.com
This crypto treasury company says its treasury is 3.4x its market value - Stock Titan
Revenue per share of BNB Plus Corp. – GETTEX:UDJ1 - TradingView — Track All Markets
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Curious about the stocks that are showing activity after the closing bell on Tuesday? - ChartMill
BNBX: BNB Plus Corp.Options Chain - Zacks Investment Research
BNBX Stock Price, Quote & Chart | BNB PLUS CORP (NASDAQ:BNBX) - ChartMill
BNB Plus Corp. (UDJ1.F) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore
MTVA PE Ratio & Valuation, Is MTVA Overvalued - Intellectia AI
Director at BNB PLUS CORP. (BNBX) granted 77,038 incentive stock options at $0.69 - Stock Titan
Director at BNB Plus (BNBX) awarded 77,038 incentive stock options - Stock Titan
[Form 4] BNB PLUS CORP. Insider Trading Activity - Stock Titan
BNB Plus (NASDAQ: BNBX) director awarded 77,038-share stock option - Stock Titan
BNB PLUS (BNBX) chairman Joshua Kruger receives options on 77,038 shares - Stock Titan
BNB PLUS (NASDAQ: BNBX) director receives grant of 77,038 stock options at $0.69 - Stock Titan
BNB Plus Faces Nasdaq Delisting Risk After Bid Price Breach - The Globe and Mail
Comstock MultiChain Fund, L P Engages with BNB Plus Corp - MarketScreener
BNB Plus Corp. receives Nasdaq delisting notice for bid price non-compliance - Investing.com India
Comstock fund reports 9.9% BNB Plus (BNBX) ownership and warrant stake - Stock Titan
Richard L. Shorten Discloses Investment at BNB Plus Corp. with 9.99% Stake - TradingView
BNB Plus Received Notice of Delisting - TradingView
BNB Plus (NASDAQ: BNBX) faces Nasdaq delisting risk after $1 bid price breach - Stock Titan
Form 10-QQuarterly Reports - Stock Titan
If You Invested $1,000 in Applied Dna Scie (APDN) - Stock Titan
BNB Plus Corp.: Fundamental Analysis and Financial Ratings | UDJ1 | US03815U6073 - marketscreener.com
BNBX Subsidiary Gains Patent For Enhanced RNA Synthesis - blockzeit.com
BNB Plus Corp. Announces European Patent Grant for Fundamental Technology Underlying its Linea™ IVT Platform - EIN News
BNB Plus lands EU patent on enzyme to speed mRNA drug output - Stock Titan
BNBX | BNB Plus Corp. Common Insider Trading - Quiver Quantitative
BNBX | BNB Plus Corp. Common Institutional Ownership - Quiver Quantitative
BNBX | BNB Plus Corp. Common Stock Data, Price & News - Quiver Quantitative
CEA Industries Appoints Brent Miller as Chief Financial Officer - GlobeNewswire
APDN SEC FilingsApplied Dna Scie 10-K, 10-Q, 8-K Forms - Stock Titan
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
BNBX Earnings History & Surprises | EPS & Revenue Results | BNB PLUS CORP (NASDAQ:BNBX) - ChartMill
MDJM Ltd (UOKA) - MSN
Crypto Currents: Meta plans entry into stablecoin space - TipRanks
BNBX Should I Buy - Intellectia AI
Capital One Financial Corp Stock Moved Up by 4.72% on Feb 25: Drivers Behind the Movement - TradingKey
BNB Plus’ Biopharma subsidiary LineaRx lands major LineaDNA orders - Indian Pharma Post
Finanzdaten der Bnb Plus Corp-Aktie (BNBX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.51%
0.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):